HIV Reservoir Discovered Within Lungs
October 3, 2014
One of the most active areas of HIV cure research focuses on the cell reservoirs where latent virus is believed to be hiding, out of the reach of existing antiretroviral therapy. Despite considerable research in this area over the past several years, there is still a great deal we don't know about how these reservoirs form -- or even where they are all located. Without deepening this knowledge, taking the next steps toward eradicating those reservoirs may not be possible.
In a poster presentation at ICAAC 2014, Henry Mwandumba, Ph.D., the Wellcome Intermediate Clinical Fellow and a clinical senior lecturer with the Malawi-Liverpool-Wellcome Trust Clinical Research Programme, revealed research findings that appear to clearly indicate the presence of HIV reservoirs in alveolar macrophages within the lung tissue of patients on antiretroviral therapy.
Mwandumba et al's study involved 54 volunteers recruited at the Queen Elizabeth Central Hospital in Blantyre, Malawi. Five of the volunteers were HIV negative, 12 were HIV positive but had never received treatment, and 37 were receiving antiretroviral therapy (all but 10 had an undetectable viral load). Bronchoalveolar lavages were conducted, and HIV-infected alveolar macrophages were found to be present in small but significant percentages of all three subsets of volunteers.
I spoke with Dr. Mwandumba at ICAAC 2014 about the study's findings. (You can also read about additional study data in NATAP's poster summary.)
Is this the first evidence we've seen that HIV reservoirs actually exist in the lungs?
For some time, people have known that alveolar macrophages can get infected with HIV. But this is really the first time that we're showing that HIV does persist in these cells, even when patients go into antiretroviral therapy.
Did the treatment an HIV-positive person was on have any effect on the extent to which you could still see HIV in the macrophages?
Not very much. The decrease in the frequency of HIV-infected alveolar macrophages was only minimal if you compare those who had been on antiretrovirals for, say, more than four years, compared to antiretroviral-naive individuals.
Actually, this is very consistent with what has been observed in the peripheral blood. If you look at reservoir cells in peripheral blood in individuals who are on antiretroviral therapy, that doesn't seem to change very much with treatment.
It reaches a very low level.
That's right. Once they've reached the plateau, it doesn't move too much after that. That's what probably we're observing in the lung, as well: You get a decrease to begin with, but then it kind of flattens off -- but doesn't go away completely.
What does this mean in terms of our approach toward ultimately trying to develop a means for eradication or a cure?
My take is that this is a large body of cells that have a virus that really hasn't been characterized properly. And in any efforts to find strategies to eradicate viral reservoirs in other sites, the lungs should be considered, because alveolar macrophages are a huge part of [the cell population]; you're talking of millions of cells in this compartment. If you have about 2% of them infected with HIV, then you're talking about large numbers of cells that can potentially seed virus into the peripheral circulation if somebody, say, stops treatment, or if their treatment fails.
So whatever strategies are being considered for eradicating virus in other reservoirs, the lungs should really be considered as an important site.
Case Report: Stem Cell Transplantation From CCR5 Delta-32 Homozygous Donor Selects for X4-Tropic HIV
This article was provided by TheBodyPRO. It is a part of the publication The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2014).
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.